This week saw the Joint IMDRF / Stakeholder (DITTA-GMTA) Workshop on the 25-26 September in Berlin

This week saw the Joint IMDRF / Stakeholder (DITTA-GMTA) Workshop on the 25-26 September in Berlin. The focus was on specialised regulatory pathways including pathways for innovative medical devices. Key highlights from the session included the opportunities for harmonisation based on the principles laid down by the IMDRF. The session also considered opportunities for innovative device pathways, including the MHRA IDAP…